Characterisation of the Expression of Neurotensin and Its Receptors in Human Colorectal Cancer and Its Clinical Implications

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.

(2019) Eric J. Norris et al.   JOURNAL OF PATHOLOGY

Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma

(2019) Teng Deng et al.   MEDICAL SCIENCE MONITOR

Exploratory Analysis of Plasma Neurotensin as a Novel Biomarker for Early Detection of Colorectal Polyp and Cancer

(2019) Shengyang Qiu et al.   Hormones & Cancer

Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use

(2019) Tingting He et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine

(2019) Thomas Langbein et al.   JOURNAL OF NUCLEAR MEDICINE

Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma

(2019) Qiqi Wu et al.   Experimental and Therapeutic Medicine

Bioinformatics and functional analyses of key genes in smoking‑associated lung adenocarcinoma

(2019) Dajie Zhou et al.   Oncology Letters

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

(2018) J. Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody

(2018) Zherui Wu et al.   CANCER LETTERS

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology

(2017) Antonia R. Sepulveda et al.   JOURNAL OF CLINICAL ONCOLOGY

177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results

(2017) Richard P. Baum et al.   JOURNAL OF NUCLEAR MEDICINE

Proof of Therapeutic Efficacy of a 177 Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model

(2017) Jörg Schulz et al.   JOURNAL OF NUCLEAR MEDICINE

A Review of the Role of Neurotensin and Its Receptors in Colorectal Cancer

(2017) Shengyang Qiu et al.   Gastroenterology Research and Practice

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

(2016) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer

(2016) Piero Dalerba et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) R. Labianca et al.   ANNALS OF ONCOLOGY

Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer

(2012) Rafal Dziadziuszko et al.   Journal of Thoracic Oncology

Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1

(2011) Ji-Gang Wang et al.   NEUROPEPTIDES

Neurotensin Receptor 1 Is Expressed in Gastrointestinal Stromal Tumors but Not in Interstitial Cells of Cajal

(2011) Petra Gromova et al.   PLoS One

Neurotensin Receptor 1 Determines the Outcome of Non-Small Cell Lung Cancer

(2010) M. Alifano et al.   CLINICAL CANCER RESEARCH

Cancer, Chemistry, and the Cell: Molecules that Interact with the Neurotensin Receptors

(2009) Rebecca M. Myers et al.   ACS Chemical Biology

The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression

(2009) Sandra Dupouy et al.   PLoS One

Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma

(2008) Xianyong Gui et al.   PEPTIDES